After Hours

16:47 WSTL Westell Tech reports Q3 (Dec) results, revs in-line; guides Q4 EPS below consensus, revs below consensus (1.52 )

Reports Q3 (Dec) loss of $0.04 per share, includes items, may not be comparable to the First Call consensus of ($0.06); revenues fell 29.9% year/year to $44.4 mln vs the $44.1 mln consensus. Co issues downside guidance for Q4, sees EPS of $(0.04)-(0.03) vs. ($0.02) consensus; sees Q4 revs of $43-45 mln vs. $51.22 mln consensus.
16:46 TRMB raisess Q4 EPS to $0.28-0.29 vs $0.25 First Call consensus; revs to $311-313 mln vs $295.72 mln First Call consensus

16:42 TRMB Trimble Navigation announces stock repurchase program for up to $250 mln (23.85 -0.52)

16:42 SCA Security Capital Assurance provides update on its capital plan (3.79 +1.64)

The co announces that it has determined not to raise new capital at the present time due to current market conditions. The co is continuing to pursue the other elements of its capital plan including, seeking to generate capital through reinsurance arrangements and restructuring certain insured obligations. “The unprecedented uncertainty and instability affecting our industry make it impractical to consider raising new capital at the present time. Pending greater clarity, we intend to continue pursuing the other components of our capital plan and consider all options available to us,” commented Paul S. Giordano, president and chief executive officer of SCA.
16:40 SOV Sovereign Banc misses by $0.04 (11.13 +1.01)

Reports Q4 (Dec) earnings of $0.18 per share, $0.04 worse than the First Call consensus of $0.22. Co says they are discontinuing their quarterly common stock dividend to help bolster capital and mitigate risk during the ongoing challenges in the financial services industry.
16:40 VARI Varian beats by $0.02, beats on revs (56.80 -0.03)

Reports Q1 (Dec) earnings of $0.66 per share, excluding non-recurring items, $0.02 better than the First Call consensus of $0.64; revenues rose 8.9% year/year to $237.4 mln vs the $233.6 mln consensus.
16:39 WSTL sees Q4 $(0.04)-(0.03) vs ($0.02) First Call consensus; sees revs $43-45 mln vs $51.22 mln First Call consensus

16:39 WSTL prelim ($0.04), includes charges, may not be comparabe to ($0.06) First Call consensus; revs $44.4 mln vs $44.13 mln First Call consensus

16:38 RJF Raymond James misses by $0.11, misses on revs (29.20 +0.89)

Reports Q1 (Dec) earnings of $0.47 per share, $0.11 worse than the First Call consensus of $0.58; revenues rose 13.6% year/year to $685.8 mln vs the $704.2 mln consensus.
16:38 BONDX Bond Watch: Crash & Burn

Bonds fell apart after the close, as stocks regrouped & rallied on the happy talk of the government bailing out of bond insurers. The short end leading the market’s fall & it accelerated after taking out 3.48% on the 10-yrs. Trade has given back nearly all of the week’s gains now, with the 10-yr -1-16/32 yielding 3.611%.
16:38 QTM Quantum DLT reports EPS in-line, misses on revs (2.81 -0.10)

Reports Q3 (Dec) earnings of $0.07 per share, excluding non-recurring items, in-line with the First Call consensus of $0.07; revenues fell 16.2% year/year to $253 mln vs the $267.2 mln consensus.
16:37 TSS Total System beats by $0.03, reports revs in-line; guides FY08 EPS above consensus, revs in-line (21.06 +0.70)

Reports Q4 (Dec) earnings of $0.34 per share, excluding non-recurring items, $0.03 better than the First Call consensus of $0.31; revenues fell 9.0% year/year to $458.5 mln vs the $454.6 mln consensus. Co increases guidance for FY08, sees EPS of $1.34-1.36 vs. $1.32 consensus; sees FY08 revs of $1.93-1.96 bln vs. $1.95 bln consensus.
16:37 ABK AMBAC Fincl: S&P puts 475 Ambac-related U.S. ABS rtgs on watch neg – DJ (13.70 +5.73) -Update-

16:35 LINC Lincoln Educational Services clarifies impact of alternative lending arrangements, will have a minimal impact (11.88 +0.51)

Co announces that it received a termination letter for its tiered discount loan program provided by Sallie Mae (SLM), effective February 18, 2008. It is co’s understanding that SLM has terminated its tiered discount program for all schools. As a result of the changes that SLM had made to its lending practices that led to the tiered program and in anticipation of changes in student financing, co has already taken steps to minimize the use of SLM funds to finance our students’ education. Co believes that SLM’s decision to terminate its tiered discount loan program will have a minimal impact.
16:35 POT Potash Earnings Preview (120.15 -2.47) -Update-

POT is expected to report 4Q07 earnings tomorrow before the market open. Current Q4 consensus calls for EPS of $0.98 and revs of $1.24 bln. The co usually provides financial guidance in the press release. Guidance: On Oct 25, co reaffirmed guidance for FY07, sees EPS of $3.00-3.25 vs. $3.24 consensus… Segment revenues: Potash (33%), nitrogen (34%) and phosphate (33%). Past Performance: POT has beaten earnings in the last three quarters by $0.04-0.13 per share. Last quarter, the co beat by $0.04 and beat on revs… POT will be the first of the fertilizer group to report earnings, and there are current debates about how much planting will be shifted from corn acres to soybeans and wheat this coming crop season. And this is very important to POT because corn requires more fertilizer use per acre over the other major crops. The fertilizer group has declined with the market recently, but isn’t exactly running on the same cycle as the market, especially considering the huge run-up in agriculture commodity prices. This is why it’s difficult to precisely explain to large declines to group has been seeing. Although, ag prices are down today, these higher commodity prices naturally gives farmers additional incentive to optimize the use of fertilizer and try to maximize yields and protect soil fertility, hence higher fertilizer sales. Areas of focus on the Call: Topics include volume growth, pricing power, ability to pass along higher input costs, and what the co thinks crop rotation may look like this crop year (e.g. how much in corn acres planted may be shifted to wheat and soybeans). What’s key in the cos report tomorrow is where volumes and inventories are at and what’s the co’s outlook is in these areas, as well as where ocean freight rates are. Last quarter, ocean freight rates have been knocking down some of the favorable pricing power POT is receiving. Last quarter: North American realized prices contributed to this result, improving by 20% ($33 per tonne) quarter over quarter. Total volumes (2.2 mln tonnes in Q3); Total volumes of 2.2 mln tonnes were up 3% from last year’s third quarter and year-to-date volumes were 42% ahead of 2006 totals. Ending inventories yr/yr (41% lower in Q3)… POT should guide for Q1 and 2008 tomorrow morning. It’s more likely that the co will guide above consensus, mainly due to continued higher commodity prices, and the ability to pass along higher input costs. Consensus for Q1 is currently $1.20 EPS and $1.35 bln in revs; FY08 is currently at $5.87 EPS and $5.92 bln in revs. Secondary Plays: MOS, TRA, CF, TNH, AGU… Technical Levels of Interest: Please see the Levels of Interest. (PVIEW)
16:34 EFII Elec For Imaging reports EPS in-line, revs in-line; reaffirms Q1 EPS guidance, revs guidance (12.98 +0.07)

Reports Q4 (Dec) earnings of $0.23 per share, in-line with the First Call consensus of $0.23; revenues fell 0.9% year/year to $152 mln vs the $152 mln consensus. Co reaffirms guidance for Q1, sees EPS of $0.18-0.20 vs. $0.19 consensus; sees Q1 revs of $133-137 mln vs. $134.34 mln consensus.
16:34 CHIC Charlotte Russe beats by $0.01, reports revs in-line; guides Q2 EPS in-line (15.98 +1.03)

Reports Q1 (Dec) earnings of $0.56 per share, $0.01 better than the First Call consensus of $0.55; revenues rose 13.9% year/year to $238.2 mln vs the $238.2 mln consensus. Co issues in-line guidance for Q2, sees EPS of 0.12-0.15 vs. $0.14 consensus. Comparable store sales for the period increased 1.5%.
16:34 QTM prelim $0.07 vs $0.07 two analyst est; revs $253 mln vs $267.20 mln two analyst est

16:34 QLGC QLogic beats by $0.03, beats on revs (13.18 +0.48)

Reports Q3 (Dec) earnings of $0.30 per share, excluding non-recurring items, $0.03 better than the First Call consensus of $0.27; revenues rose 0.3% year/year and 13% sequentially to $158.0 mln vs the $155.6 mln consensus.
16:33 TSS sees FY08 $1.34-1.36 vs $1.32 First Call consensus; sees revs $1.93-1.96 bln vs $1.95 bln First Call consensus

16:33 SVN Sun-Times Media announces receipt of notice of proposed adjustments from Internal Revenue Service (1.76 +0.16)

The co announces that it has received an examination report from the IRS setting forth proposed changes to the co’s U.S. tax returns for 1996 through 2003. The co intends to request a conference with the Appeals Office of the IRS to seek reconsideration of disputed proposed adjustments contained in the report. The co is evaluating the impact that the proposed adjustments may have on its financial statements, including whether the co’s accruals for U.S. tax contingencies should be adjusted and, if so, the period or periods when such accrual adjustments may be recorded.
16:33 EPIX EPIX Pharma achieves $1.25 mln milestone in collaboration with Cystic Fibrosis Foundation Therapeutics (2.72 -0.18)

The co announces that it has received a $1.25 mln milestone payment from Cystic Fibrosis Foundation Therapeutics, the nonprofit affiliate of the Cystic Fibrosis Foundation. This milestone marks EPIX and CFFT’s successful completion of the development of a validated model of a full-length Cystic Fibrosis Transmembrane conductance Regulator ion channel protein. A mutation in the CFTR gene that codes for this channel is one of the key factors that ultimately lead to the symptoms, complications and premature mortality in people with cystic fibrosis.
16:32 FPTB First PacTrust Bancorp announces stock repurchase program of up to 150k shares or 3.4% outstanding (16.75 -0.25)

16:32 CNS Cohen & Steers beats by $0.02, beats on revs (26.15 +3.46)

Reports Q4 (Dec) earnings of $0.44 per share, $0.02 better than the First Call consensus of $0.42; revenues rose 16.1% year/year to $66.9 mln vs the $63.8 mln consensus.
16:32 TSS prelim $0.34 vs $0.31 First Call consensus; revs $458.51 mln vs $454.55 mln First Call consensus

16:31 MTSC MTS Systems misses by $0.10, beats on revs; reaffirms FY08 EPS guidance, revs guidance (37.59 +0.06)

Reports Q1 (Dec) earnings of $0.47 per share, $0.10 worse than the First Call consensus of $0.57; revenues rose 11.1% year/year to $110.1 mln vs the $106.5 mln consensus. Co reaffirms guidance for FY08, sees EPS of $2.43-2.53 vs. $2.51 consensus; sees FY08 revs of $440-450 mln vs. $446.64 mln consensus. THe decrease was driven by higher income tax expense of $1.3 million and lower income from operations, partially offset by an estimated $0.2 million favorable impact of currency translation.
16:31 PTV Pactiv Corp beats by $0.02, reports revs in-line; guides Q1 EPS below consensus; guides FY08 EPS in-line, revs in-line (24.70 +0.31)

Reports Q4 (Dec) earnings of $0.45 per share, $0.02 better than the First Call consensus of $0.43; revenues rose 18.7% year/year to $876 mln vs the $868 mln consensus. Co issues downside guidance for Q1, sees EPS of $0.30-0.33, excluding restructuring charges, vs. $0.45 consensus. Co issues in-line guidance for FY08, sees EPS of $2.00-2.10 vs. $2.05 consensus; sees FY08 revs of $3.578-3.708 bln vs. $3.58 bln consensus.
16:31 PLXS Plexus misses by $0.02, reports revs in-line; guides Q2 EPS above consensus, revs above consensus (19.84 +1.30)

Reports Q1 (Dec) earnings of $0.58 per share, $0.02 worse than the First Call consensus of $0.60; revenues rose 20.4% year/year to $458.3 mln vs the $454.1 mln consensus. Co issues upside guidance for Q2, sees EPS of $0.46-0.51, excluding non-recurring items, vs. $0.42 consensus; sees Q2 revs of $440-460 mln vs. $429.61 mln consensus.
16:31 TO Tech/Ops Sevcon, Inc. appoints Paul Farquhar as Chief Financial Officer (7.60 +0.60)

Co announces Paul McPartlin retired as Vice President and Chief Financial Officer and Board has appointed Paul Farquhar as new Chief Financial Officer.
16:31 CHIC sees Q2 $0.12-0.15 vs $0.14 First Call consensus

16:31 QLGC prelim $0.30 vs $0.27 First Call consensus; revs $158.0 mln vs $155.6 mln First Call consensus

16:31 CVO Cenveo reaffirms FY08 guidance (12.76 -0.64)

Co reiterates 2008 guidance of over $300 mln of Adjusted EBITDA and over $130 mln in free cash flow. “Given the recent volatility in the financial markets and the Company’s share price, I wanted to reiterate to our shareholders that our business plan remains on track.”
16:31 First PacTrust Bancorp announces stock repurchase program of up to 150,000 shares (16.75 -0.25)

16:30 CNS prelim $0.44 vs $0.42 First Call consensus; revs $66.9 mln vs $63.77 mln First Call consensus

16:30 CHIC prelim $0.56 vs $0.55 First Call consensus; revs $238.2 mln vs $238.20 mln First Call consensus

16:28 RYL Ryland Group reports Q4 results (31.22 +4.20)

Reports Q4 (Dec) loss of $4.80 per share, which includes inventory valuation adjustments and write-offs and an income tax charge, and an ex-items profit of $0.53; vs First Call consensus of ($0.17). Revenues fell 37.0% year/year to $854.1 mln vs the $819.7 mln consensus.
16:28 SHRP Sharper Image and EB Brands sign multiyear licensing agreement (2.35 +0.41) -Update-

Co announces the signing of a multiyear licensing agreement with EB Brands. Under this agreement, EB Brands will offer men’s gifts–including automotive, golf, and household accessories–associated with The Sharper Image name. These new products are scheduled for a mid-2008 launch at Sharper Image stores, catalog and website, and at select mid-tier and high-end department stores.
16:27 SYMC Symantec beats by $0.04, beats on revs; guides Q4 EPS above consensus, revs above consensus (15.26 +0.24)

Reports Q3 (Dec) earnings of $0.33 per share, $0.04 better than the First Call consensus of $0.29. Co issues upside guidance for Q4, sees EPS of $0.33-$0.35 vs. $0.30 consensus; sees Q4 revs of $1.51-$1.55 vs. $1.48 bln consensus.
16:27 KNX Knight Transportation beats by $0.01, beats on revs (16.66 +1.66)

Reports Q4 (Dec) earnings of $0.18 per share, excluding $0.02 per share after tax, increase to auto liability claims reserves relating primarily to the settlement of certain claims incurred in a prior year, $0.01 better than the First Call consensus of $0.17; revenues rose 6.6% year/year to $186.5 mln vs the $176 mln consensus.
16:26 ISIL Intersil beats by $0.01, beats on revs; guides Q1 EPS in-line, revs in-line (23.22 +1.14)

Reports Q4 (Dec) earnings of $0.39 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $0.38; revenues rose 17.4% year/year to $212.6 mln vs the $210.2 mln consensus. Co issues in-line guidance for Q1, sees EPS of $0.35-0.36 vs. $0.36 consensus; sees Q1 revs of $199.8-206.2 mln vs. $203.04 mln consensus. Co says, “Demand for our products is basically consistent with normal seasonality. In the Q1, we typically experience a sequential decline in our consumer and computing markets.”
16:26 SHRP Sharper Image and EB Brands sign licensing agreement (2.29 +0.41)

The co announces the signing of a multiyear licensing agreement with EB Brands, a manufacturer and marketer of men’s gifts and accessories items.
16:25 SANM Sanmina-SCI beats by $0.01, beats on revs; guides Q2 EPS in-line, revs above consensus (1.41 +0.19)

Reports Q1 (Dec) earnings of $0.04 per share, $0.01 better than the First Call consensus of $0.03; revenues rose 0.9% year/year to $2.53 bln vs the $2.42 bln consensus. Co issues mixed guidance for Q2, sees EPS of $0.03-0.05 vs. $0.03 consensus; sees Q2 revs of $2.4-2.5 bln vs. $2.35 bln consensus.
16:25 PLCM Polycom beats by $0.03, beats on revs (22.28 -0.29)

Reports Q4 (Dec) earnings of $0.42 per share, excluding non-recurring items, $0.03 better than the First Call consensus of $0.39; revenues rose 41.2% year/year to $263.3 mln vs the $252.5 mln consensus.
16:25 TECHX Equity markets stage strong, high volume, broad based rally in final hour of trade

Beginning at 3:00p.m. Est the broad markets staged an impressive rally fueled by both aggressive buying & short covering. Key short-term resistance levels/price points were breached in both the futures & cash indices giving numerous positive short-term technical signals. The Dow Industrials reclaimed the 12,000 level in a session that saw the average trade over 600pts from low to high. All of the major indices settled in positive territory except for the Nasdaq 100 which was dragged down by AAPL (-10.50%), AMZN (-5.75%), GOOG (-6.10%), & RIMM (-2.3%). Unofficially, the INDU ended @ 12270 +299, SPX @ 1338 +28, COMPQ @ 2316 +24, & RUT @ 693 +22. Sector strength seen in homebuilders (XHB +10.5%), REITS (IYR +7.8%), Regional Banks (RKH +7.8%), Financials (XLF +7.1%), & Transports (IYT +6.85%) while weakness was seen in Commodities (DBC -1.9%), Energies (USO -1.5%), & Biotech (BBH -0.65%).
16:24 PSSI PSS World Med misses by $0.01, reports revs in-line; reaffirms FY08 EPS guidance (18.07 -1.47)

Reports Q3 (Dec) earnings of $0.22 per share, $0.01 worse than the First Call consensus of $0.23; revenues rose 1.5% year/year to $465.2 mln vs the $467.1 mln consensus. Co reaffirms guidance for FY08, sees EPS of $0.81-0.85 vs. $0.83 consensus.
16:24 FUR Winthrop Realty Trust announces proposed shareholder rights offering (5.69 +0.36)

Co announced that it has filed a registration statement with the Securities and Exchange Commission for a proposed rights offering to holders of its Common Shares of Beneficial Interest and holders of its Series B-1 Cumulative Convertible Redeemable Preferred Shares of Beneficial Interest. Upon the effectiveness of the registration statement, the co intends to distribute non-transferable subscription rights to subscribe for and purchase up to an aggregate of 8,845,036 of its common shares of beneficial interest to holders of record as of the record date, which has not yet been determined. The exercise price for the rights has not yet been determined, but will not be less than the greater of $5.02 or 96% of the average closing price of common shares for five consecutive trading days during a period selected by the co.
16:23 PRXL PAREXEL beats by $0.01, beats on revs; guides Q3 EPS in-line, revs above consensus; guides FY08 EPS above consensus, revs above consensus (50.26 -1.07)

Reports Q2 (Dec) earnings of $0.40 per share, $0.01 better than the First Call consensus of $0.39; revenues rose 57.5% year/year to $284.2 mln vs the $222.8 mln consensus. Co issues mixed guidance for Q3, sees EPS of $0.42-0.44 vs. $0.43 consensus; sees Q3 revs of $240-250 mln vs. $232.11 mln consensus. Co issues upside guidance for FY08, sees EPS of $1.78-1.83 vs. $1.65 consensus; sees FY08 revs of $935-955 mln vs. $907.20 mln consensus.
16:22 ACXM Acxiom misses by $0.02, misses on revs; issues FY08 guidance (9.00 -0.09)

Reports Q3 (Dec) earnings of $0.20 per share, excluding non-recurring items, $0.02 worse than the First Call consensus of $0.22; revenues fell 0.6% year/year to $350.3 mln vs the $355.1 mln consensus. Co issues FY08 rev guidance, sees EPS of $0.81-0.86 ex items, may not be comparable to $0.71 consensus; sees FY08 revs flat to down 1% YoY, or roughly $1.38-1.4 bln vs. $1.4 bln consensus… In December 2005, the co and EMC entered into an agreement whereby EMC purchased Acxiom’s existing grid operating system for a total payment of $30 mln, which the co previously received. As part of the agreement, EMC has the option, in exchange for a $20 mln payment by the end of January, to acquire the Acxiom unit responsible for the further development of the technology initially sold to EMC as well as new technology and functionality created by the unit that could be utilized by the co and EMC. EMC has informed the company that it does not intend to exercise the option, per its original terms, and the parties are now engaged in negotiations concerning an ongoing commercial relationship.
16:22 CLDN Celadon Group misses by $0.01, beats on revs (8.79 +0.44)

Reports Q2 (Dec) earnings of $0.08 per share, $0.01 worse than the First Call consensus of $0.09; revenues rose 12.8% year/year to $138.6 mln vs the $132.5 mln consensus.
16:21 SRDX SurModics reports EPS in-line, beats on revs (50.22 +0.51)

Reports Q1 (Dec) earnings of $0.31 per share, in-line with the First Call consensus of $0.31; revenues rose 42.5% year/year to $23.8 mln vs the $23.1 mln consensus.
16:21 MRCY Mercury Computer beats by $0.09, reports revs in-line; guides Q3 EPS below consensus, revs below consensus; guides FY08 EPS below consensus, revs below consensus (13.08 +0.21)

Reports Q2 (Dec) earnings of $0.04 per share, $0.09 better than the First Call consensus of ($0.05). Co issues downside guidance for Q3, sees EPS of $(0.04)-0.00 vs. $0.10 consensus; sees Q3 revs of $53-55 mln vs. $57.88 mln consensus. Co issues downside guidance for FY08, sees EPS of $0.08-0.17 vs. $0.34 consensus; sees FY08 revs of $209-214 mln vs. $224.20 mln consensus.
16:20 DGII Digi Intl misses by $0.03, reports revs in-line; reaffirms FY08 EPS in-line, revs in-line (13.51 +0.02)

Reports Q1 (Dec) earnings of $0.14 per share, $0.03 worse than the First Call consensus of $0.17; revenues rose 6.7% year/year to $44.6 mln vs the $44.9 mln consensus. Co reaffirms in-line guidance for FY08, sees EPS of $0.69-0.87 vs. $0.76 consensus; sees FY08 revs of $197-207 mln vs. $201.11 mln consensus.
16:20 SYK Stryker reports EPS in-line, beats on revs; guides FY08 EPS in-line (66.69 +1.94)

Reports Q4 (Dec) earnings of $0.66 per share, in-line with the First Call consensus of $0.66; revenues rose 18.4% year/year to $1.66 bln vs the $1.6 bln consensus. Co issues in-line guidance for FY08, sees EPS of $2.88 vs. $2.88 consensus. Co says their outlook for 2008 continues to be optimistic regarding underlying growth rates in orthopaedic procedures and sales growth rates in the co’s broadly based range of products in orthopaedics and other medical specialties, despite the potential for continued pricing pressure in certain markets. The co says the financial forecast for 2008 includes a constant currency net sales increase in the range of 11% to 13% (this calculates to roughly $6.613- 6.732 bln vs $6.721 bln consensus) as a result of growth in shipments of Orthopaedic Implants and MedSurg Equipment. If foreign currency exchange rates hold near current levels, the co anticipates a favorable impact on net sales of approx 2.5% to 3% in the first quarter of 2008 and a favorable impact on net sales of approx 1% to 1.5% for the full year of 2008.
16:19 LSI LSI Logic beats by $0.06, beats on revs; guides Q1 EPS in-line, revs in-line (4.01 +0.09)

Reports Q4 (Dec) earnings of $0.13 per share, $0.06 better than the First Call consensus of $0.07; revenues rose 1.8% year/year to $740.8 mln vs the $714 mln consensus. Co issues in-line guidance for Q1, sees EPS of 0.05-0.09 vs. $0.06 consensus; sees Q1 revs of $620-$650 mln vs. $644.51 mln consensus. “Despite uncertain economic conditions, our business remains healthy and our forward looking guidance for the first quarter is within our expected range of seasonality.”
16:19 EBAY eBay beats by $0.04, beats on revs; guides Q1 EPS below consensus, revs below consensus; guides FY08 EPS in-line, revs below consensus (28.94 +1.81)

Reports Q4 (Dec) earnings of $0.45 per share, $0.04 better than the First Call consensus of $0.41. Co issues downside guidance for Q1, sees EPS of $0.37-0.39 vs. $0.40 consensus; sees Q1 revs of $2.0-2.05 bln vs. $2.15 bln consensus. Co issues mixed guidance for FY08, sees EPS of $1.63-1.67 vs. $1.66 consensus; sees FY08 revs of $8.50-8.75 bln vs. $9.02 bln consensus.
16:19 PSSI prelim $0.22 vs $0.23 First Call consensus; revs $465.2 mln vs $467.12 mln First Call consensus

16:19 CTXS Citrix Systems beats by $0.06, beats on revs; guides Q1 EPS in-line, revs in-line; guides FY08 EPS in-line, revs in-line (32.00 -0.87)

Reports Q4 (Dec) earnings of $0.49 per share, excluding non-recurring items, $0.06 better than the First Call consensus of $0.43; revenues rose 24.6% year/year to $400 mln vs the $380.4 mln consensus. CTXS says product license revenue increased 24%. Co announces a $300 mln common stock repurchase program. Co issues in-line guidance for Q1, sees EPS of $0.33-0.35, excluding non-recurring items, vs. $0.35 consensus; sees Q1 revs of $367-377 mln vs. $367.63 mln consensus. Co issues in-line guidance for FY08, sees EPS of $1.61-1.64, excluding non-recurring items, vs. $1.62 consensus; sees FY08 revs of $1.615-1.645 bln vs. $1.61 bln consensus.
16:19 PTV sees Q1 $0.30-0.33 vs $0.45 First Call consensus

16:19 WDC Western Digital beats by $0.31, beats on revs (24.94 +0.89)

Reports Q2 (Dec) earnings of $1.35 per share, $0.31 better than the First Call consensus of $1.04; revenues rose 24.8% year/year to $2.2 bln vs the $2.05 bln consensus.
16:18 PTV sees FY08 $2.00-2.10 vs $2.05 First Call consensus; sees revs $3.58-3.71 bln vs $3.58 bln First Call consensus

16:17 MOLX Molex beats by $0.02, beats on revs; guides Q3 EPS in-line, revs above consensus (22.00 -0.81)

Reports Q2 (Dec) earnings of $0.35 per share, $0.02 better than the First Call consensus of $0.33. Co issues mixed guidance for Q3, sees EPS of $0.33-0.37 vs. $0.35 consensus; sees Q3 revs of $820-860 vs. $819.21 mln consensus.
16:17 EBAY sees FY08 $1.63-1.67 vs $1.66 First Call consensus; sees revs $8.50-8.75 bln vs $9.02 bln First Call consensus

16:17 CTO Consolidated-Tomoka Land Board Chairman Bob Allen to retire (54.19 +3.24)

16:16 RYL prelim $0.53 vs ($0.17) First Call consensus; revs $854.1 mln vs $819.73 mln First Call consensus

16:16 GILD Gilead Sciences beats by $0.01, reports revs in-line (44.81 +0.60)

Reports Q4 (Dec) earnings of $0.41 per share, $0.01 better than the First Call consensus of $0.40; revenues rose 21.7% year/year to $1.09 bln vs the $1.09 bln consensus. Gilead Sciences reported 4Q07 HIV Franchise rev of $864.2 mln vs. $841 mln Street Expectations; 4Q07 Truvada W.W. rev of $448.8 mln vs. $412 mln Steet Expectations; 4Q07 Atripla W.W. rev of $259.7 mln vs. $279 mln Street Expectaitions… Co’s secondary drugs: 4Q07 Viread W.W. rev of $148.5 mln vs. $143 mln Street Expectations; 4Q07 Emtriva W.W. rev of $7.1 mln vs. $7.98 mln Street Expectations; 4Q07 Hepsera rev of $76.9 mln vs. $80.39 mln; 4Q07 AmBisome rev of $67.8 mln vs. $68.5 mln Street Expectations
16:16 EBAY sees Q1 $0.37-0.39 vs $0.40 First Call consensus; sees revs $2.0-2.05 bln vs $2.15 bln First Call consensus

16:16 COF Capital One misses by $0.03, misses on revs (44.22 +4.40)

Reports Q4 (Dec) net income of $0.60 per share, compared to 01/10 guidance of “about $0.60″ and income from continuing operations of $0.85 compared to 01/10 guidance of “approximately $0.85″; total revenues rose 27.9% year/year to $3.92 bln, with total revs on a managed basis of $4.57 bln.
16:16 PTV prelim $0.45 vs $0.43 First Call consensus; revs $876 mln vs $868 mln First Call consensus

16:15 WDC prelim $1.35 vs $1.04 First Call consensus; revs $2.2 bln vs $2.05 bln First Call consensus

16:15 EBAY prelim $0.45 vs $0.41 First Call consensus; revs $2.18 bln vs $2.14 bln First Call consensus

16:15 NVEC NVE Corp beats by $0.06, beats on revs (20.26 +0.26)

Reports Q3 (Dec) earnings of $0.36 per share, $0.06 better than the First Call consensus of $0.30; revenues rose 23.6% year/year to $4.8 mln vs the $4.5 mln consensus. “We are pleased to report our best third quarter ever. Increases in product sales and operating margins drove record earnings.”
16:15 NFLX Netflix beats by $0.10, reports revs in-line; guides Q1 EPS in-line, revs above consensus; guides FY08 EPS above consensus, revs in-line (23.76 +1.45)

Reports Q4 (Dec) GAAP earnings of $0.24 per share, $0.10 better than the First Call consensus of $0.14; revenues rose 2.9% year/year to $302.4 mln vs the $301.7 mln consensus. Netflix reports net sub additions of 451K vs ~534K street expectation and co guidance of 272K-472K. Subscriber acquisition cost for Q4 was $34.60 vs $44.31 for the same period of 2006 and $37.91 in Q3. Co issues guidance for Q1, sees EPS of $0.13-0.21 vs. $0.15 consensus; sees Q1 revs of $323-328 mln vs. $320.14 mln consensus. Co issues guidance for FY08, sees EPS of $1.12-1.24 vs. $0.91 consensus; sees FY08 revs of $1.3-1.35 bln vs. $1.31 bln consensus.
16:14 CAVM Cavium Networks beats by $0.01, beats on revs (19.47 +0.05)

Reports Q4 (Dec) earnings of $0.07 per share, excluding non-recurring items, $0.01 better than the First Call consensus of $0.06; revenues rose 63.6% year/year to $16.2 mln vs the $15.6 mln consensus.
16:14 AMCC Applied Micro beats by $0.01, beats on revs (8.24 +0.47)

Reports Q3 (Dec) earnings of $0.05 per share, $0.01 better than the First Call consensus of $0.04; revenues rose 13.9% year/year to $66.3 mln vs the $65.6 mln consensus.
16:14 BKHM Bookham Tech beats by $0.05, beats on revs; guides Q3 revs in-line (2.13 +0.01)

Reports Q2 (Dec) loss of $0.01 per share, $0.05 better than the First Call consensus of ($0.06); revenues rose 8.7% year/year to $59 mln vs the $57.1 mln consensus. Co issues in-line guidance for Q3, sees Q3 revs of $56-60 mln vs. $57.83 mln consensus.
16:13 comScore releases December U.S. search engine rankings

In December, Google (GOOG) Sites’ share of core searches stood at 58.4%. Yahoo! (YHOO) Sites ranked second with 22.9%, followed by Microsoft Sites (9.8%) (MSFT) , Time Warner Network (4.6%) (TWX) , and Ask Network (4.3%). Yahoo! Sites experienced the most significant market share increase, gaining 0.5 share points versus the previous month.
16:12 CBST Cubist Pharma misses by $0.01, reports revs in-line (20.23 -0.11)

Reports Q4 (Dec) earnings of $0.16 per share, $0.01 worse than the First Call consensus of $0.17; revenues rose 51.5% year/year to $85.6 mln vs the $84.8 mln consensus. Co also reported 4Q07 Total Cubicin revs of $85.5 mln vs. $85.08 mln Street Expectations; 4Q07 U.S. Cubicin rev of $83.9 mln vs. $83.64 mln Street Expectations.
16:11 BLL Ball Corp authorizes repurchase of 12 mln shares of its common stock. (43.16 +1.04)

16:11 CME CME Group reports trading volume for Jan 22 (609.99 +28.99) -Update-

The co reached its third highest trading day of combined CME and CBOT products with 23,261,304 contracts traded for the trade date of January 22.
16:11 EFII sees Q1 $0.18-0.20 vs $0.19 First Call consensus; reaffirms revs $133-137 mln vs $134.34 mln First Call consensus

16:11 SANM sees Q2 $0.03-0.05 vs $0.03 First Call consensus; sees revs $2.4-2.5 mln vs $2.35 bln First Call consensus

16:11 FFIV F5 Networks reports EPS in-line, revs in-line; guides Q2 EPS in-line, revs in-line; also announces stock repurchase program of up to $200 mln (20.20 -0.21)

Reports Q1 (Dec) earnings of $0.21 per share, in-line with the First Call consensus of $0.21; revenues rose 28.5% year/year and 6% sequentially to $154.2 mln vs the $155.4 mln consensus. Co issues in-line guidance for Q2 (Mar), sees EPS of $0.21-0.22 vs. $0.22 consensus; sees Q2 revs of $158-160 mln vs. $160.8 mln consensus. Co also announces that its board of directors approved a new program to repurchase up to $200 mln of the co’s outstanding common stock.
16:11 SYMC sees Q4 $0.33-0.35 vs $0.30 First Call consensus; sees revs $1.51-1.55 bln vs $1.48 bln First Call consensus

16:11 QCOM Qualcomm misses by $0.01, beats on revs; guides Q2 EPS in-line, revs in-line; reaffirms FY08 EPS guidance, guides FY08 revs in-line (36.69 -0.23)

Reports Q1 (Dec) earnings of $0.52 per share, excluding non-recurring items, $0.01 worse than the First Call consensus of $0.53; revenues rose 20.8% year/year to $2.44 bln vs the $2.41 bln consensus. Co issues in-line guidance for Q2, sees EPS of $0.50-0.52, excluding non-recurring items, vs. $0.52 consensus; sees Q2 revs of $2.4-2.5 bln vs. $2.44 bln consensus. Co issues in line guidance for FY08, sees EPS of $2.01-2.07, excluding non-recurring items, vs. $2.12 consensus; sees FY08 revs of $9.6-10.0 bln, compared to previous guidance of $9.5-9.9 bln, vs. $9.83 bln consensus.
16:11 VAR Varian Medical beats by $0.03, beats on revs; issues Q2 & FY08 guidance (49.10 -0.26)

Reports Q1 (Dec) earnings of $0.43 per share, $0.03 better than the First Call consensus of $0.40; revenues rose 18.2% year/year to $458.5 mln vs the $436.2 mln consensus. Co sees Q2 EPS of $0.51 vs. $0.51 consensus; sees Q2 revs up 14-16% YoY (roughly $505-514 mln) vs. $485.49 mln consensus. Co sees FY08 EPS of $2.05-2.07 vs. $2.05 consensus; sees FY08 revs up 14% (roughly $2.03 bln) vs. $1.97 bln consensus.
16:10 EFII prelim $0.23 vs $0.23 First Call consensus; revs $152 mln vs $151.99 mln First Call consensus

16:10 SANM prelim $0.04 vs $0.03 First Call consensus; revs $2.53 bln vs $2.42 bln First Call consensus

16:10 CTXS announces a $300 mln common stock repurchase program

16:10 SYMC prelim $0.33 vs $0.29 First Call consensus; revs $1.52 bln vs $1.45 bln First Call consensus

16:09 CTXS says product license revenue increased 24%

16:09 PRXL sees FY08 $1.78-1.83 vs $1.65 First Call consensus; sees revs $1-1.04 bln vs $907.20 mln First Call consensus

16:09 ISIL sees Q1 revs down 3-6% sequentially, which equates to ~$199.8-206.2 mln vs $203.04 mln First Call consensus

16:09 CTXS sees FY08 $1.61-1.64 vs $1.62 First Call consensus; sees revs $1.615-1.645 bln vs $1.61 bln First Call consensus

16:08 PRXL sees Q3 $0.42-0.44 vs $0.43 First Call consensus; sees revs $240-250 mln vs $232.11 mln First Call consensus

16:08 FFIV sees Q2 (Mar) $0.21-0.22 vs $0.22 First Call consensus; sees revs $158-160 mln vs $160.8 mln First Call consensus

16:08 ISIL sees Q1 $0.35-0.36 vs $0.36 First Call consensus; sees revs down 3-6% sequentially

16:07 CTXS sees Q1 $0.33-0.35 vs $0.35 First Call consensus; sees revs $367-377 mln vs $367.63 mln First Call consensus

16:07 PKI PerkinElmer elects Robert Friel as Chief Executive Officer (23.00 -0.27)

Co announces that Robert Friel has been elected Chief Executive Officer by the co’s Board of Directors effective February 1, 2008. He will also retain the title of President. Gregory Summe will continue in the role of Executive Chairman of the Board, and remain as such through the Annual Shareholders meeting in April 2009.
16:07 GILD prelim $0.41 vs $0.40 First Call consensus; revs $1.09 bln vs $1.09 bln First Call consensus

16:07 LSI sees Q1 $0.05-0.09 vs $0.06 First Call consensus; sees revs $620-650 mln vs $644.51 mln First Call consensus

16:07 PPDI PPD Inc. expands Global Central Lab Services into China (44.20 -2.16)

The co announces that it has expanded its global central lab services into China through an exclusive agreement with Peking Union Lawke Biomedical Development Limited. The agreement allows PPD to begin immediately providing biopharmaceutical clients with its full range of highly customized central lab services in China.
16:07 LSI prelim $0.13 vs $0.07 First Call consensus; revs $741 mln vs $714.04 mln First Call consensus

16:07 FFIV prelim $0.21 vs $0.21 First Call consensus; revs $154.2 mln vs $155.41 mln First Call consensus

16:07 NVEC prelim $0.36 vs $0.30 First Call consensus; revs $4.77 mln vs $4.53 mln First Call consensus

16:07 ISIL prelim $0.39 vs $0.38 First Call consensus; revs $212.6 mln vs $210.23 mln First Call consensus

16:06 CTXS prelim $0.49 vs $0.43 First Call consensus; revs $400 mln vs $380.40 mln First Call consensus

16:06 PRXL prelim $0.40 vs $0.39 First Call consensus; revs $284.2 mln vs $222.80 mln First Call consensus

16:06 NFLX sees FY08 $1.12-1.24 vs $0.91 First Call consensus; sees revs $1.3-135 bln vs $1.31 bln First Call consensus

16:06 COF prelim $0.85 vs $0.63 First Call consensus; revs $4.57 bln vs $4.36 bln First Call consensus

16:06 PLCM prelim $0.42 vs $0.39 First Call consensus; revs $263.3 mln vs $252.46 mln First Call consensus

16:05 AMCC prelim $0.05 vs $0.04 First Call consensus; revs $66.3 mln vs $65.61 mln First Call consensus

16:05 NFLX sees Q1 $0.13-0.21 vs $0.15 First Call consensus; sees revs $323-328 mln vs $320.14 mln First Call consensus

16:05 MOLX prelim $0.35 vs $0.33 First Call consensus; revs $841.60 mln vs $824.84 mln First Call consensus

16:05 NFLX prelim $0.24 vs $0.14 First Call consensus; revs $302.4 mln vs $301.68 mln First Call consensus

16:05 MRCY sees FY08 $0.08-0.17 vs $0.34 First Call consensus; sees revs $209-214 mln vs $224.20 mln First Call consensus

16:04 MRCY sees Q3 $(0.04)-0.00 vs $0.10 First Call consensus; sees revs $53-55 mln vs $57.88 mln First Call consensus

16:04 SOV prelim $0.18 ex items vs $0.22 First Call consensus

16:04 MOLX sees Q3 $0.33-0.37 vs $0.35 First Call consensus; sees revs $820-860 mln vs $819.21 mln First Call consensus

16:03 MRCY prelim $0.04 vs ($0.05) First Call consensus; revs $52.6 mln vs $52.18 mln First Call consensus

16:03 DGII sees FY08 $0.69-0.87 vs $0.76 First Call consensus; sees revs $197-207 mln vs $201.11 mln First Call consensus

16:03 SRDX prelim $0.31 vs $0.31 First Call consensus; revs $23.8 mln vs $23.09 mln First Call consensus

16:03 DGII prelim $0.14 vs $0.17 First Call consensus; revs $44.6 mln vs $44.88 mln First Call consensus

16:03 MTSC reaffirms FY08 $2.43-2.53 vs $2.51 First Call consensus; sees revs $440-450 mln vs $446.64 mln First Call consensus

16:03 VAR sees Q2 $0.51 vs $0.51 First Call consensus; sees revs up 14-16%

16:03 CLDN prelim $0.08 vs $0.09 First Call consensus; revs $138.6 mln vs $132.50 mln First Call consensus

16:02 BKHM sees Q3 revs $56-60 mln vs $57.8 mln First Call consensus

16:02 CAVM prelim $0.07 vs $0.06 First Call consensus; revs $16.2 mln vs $15.59 mln First Call consensus

16:02 VAR sees FY08 $2.05-2.07 vs $2.05 First Call consensus; sees revs up 14%

16:02 MTSC prelim $0.47 including a $0.09 tax benefit, vs $0.57 First Call consensus; revs $110.1 mln vs $106.50 mln First Call consensus

16:02 BCRX BioCryst Pharm updates Peramivir clinical development plan (5.29 -0.28)

Co provided an update on activities conducted following release of the preliminary Phase II data and outlined the resulting clinical development plan for intramuscular peramivir. Following release of preliminary Phase II results in September 2007, the co completed additional analyses of the clinical data and performed a preliminary analysis of the virologic data from this trial. Preliminary analysis of the virologic data from the Phase II trial indicated that i.m. peramivir demonstrated statistically significant reductions in influenza virus shedding in both active treatment groups when compared to placebo, with greater reductions in the 300mg group. Additionally, pharmacokinetic studies have been completed that indicate that needle length impacts adequate and consistent systemic exposure to i.m. peramivir.
16:02 WGOV Woodward Governor: Gendron Named Woodward Chairman of the Board (55.71 -0.82) -Update-

16:02 CBST prelim $0.16 vs $0.17 First Call consensus; revs $85.58 mln as preannounced

16:01 PLXS prelim $0.58 vs $0.60 First Call consensus; revs $458 mln$458 mln vs $454.05 mln First Call consensus

16:01 QCOM sees FY08 $2.01-2.07 vs $2.12 First Call consensus; sees revs $9.6-10.0 bln vs $9.83 bln First Call consensus

16:01 BKHM prelim ($0.01) vs ($0.06) First Call consensus; revs $59.0 mln vs $57.1 mln First Call consensus

16:01 SYK sees FY08 $2.88 vs $2.88 First Call consensus

16:01 QCOM sees Q2 $0.50-0.52 vs $0.52 First Call consensus; sees revs $2.4-2.5 bln vs $2.44 bln First Call consensus

16:01 VAR prelim $0.43 vs $0.40 First Call consensus; revs $459 mln vs $436.24 mln First Call consensus

16:01 PLXS prelim $0.58 vs $0.60 First Call consensus; revs $$458 mln$458 mln vs $454.05 mln First Call consensus

16:01 KNX prelim $0.18 vs $0.17 First Call consensus; revs $186.5 mln vs $175.98 mln First Call consensus

16:00 QCOM prelim $0.52 vs $0.53 First Call consensus; revs $2.44 bln vs $2.41 bln First Call consensus

16:00 SYK prelim $0.66 vs $0.66 First Call consensus; revs $1.66 bln vs $1.60 bln First Call consensus

16:00 EBAY eBay confirms Meg Whitman to Step Down as President and CEO of eBay (29.00 +1.87) -Update-

Co confirms that Meg Whitman will step down as President and CEO of eBay on March 31, 2008. Whitman will remain on the company’s Board of Directors. eBay’s Board of Directors voted unanimously to elect John Donahoe President and CEO. Donahoe came to eBay in February 2005 from Bain & Company.
16:00 HLYS Heelys receives deficiency letter from NASDAQ (6.60 +0.08)

Co announced that it received a Nasdaq Staff deficiency letter on January 17, 2008 indicating that the co no longer complies with the Nasdaq audit committee requirement as set forth in Marketplace Rule 4350, which requires a listed company to have an audit committee of at least three members. As a result of James Kindley’s resignation from the Board of Directors on December 17, 2007, the Company’s audit committee presently has only two members. NASDAQ has requested the Company provide, on or before June 16, 2008, documentation evidencing compliance with Marketplace Rule 4350.